UC Berkeley launched trial of saliva test for COVID-19
On Jun. 30, 2020, scientists from the Innovative Genomics Institute (IGI) at the University of California Berkeley announced…
CIRM board approved third clinical trial for COVID-19
On Jun. 26, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $750,000 to Dr. Xiaokui Zhang at…
Flu mutation study suggested universal flu vaccine may be even more challenging than expected
On Jun. 23, 2020, scientists at Scripps Research reported that some common strains of influenza have the potential…
San Diego’s scientific and medical institutes collaborated on large-scale research program to study spread of COVID-19
On Jun. 16, 2020, a consortium that includes many of San Diego’s top medical and scientific research institutes…
CIRM board approved two additional COVID-19 projects
On Jun. 12, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $349,999 to Dr. Vaithilingaraja Arumugaswami at…
The USDA announced transition to preventive plan for virulent Newcastle disease in California
On Jun. 1, 2020, the USDA announced it is transitioning its virulent Newcastle disease (vND) efforts in southern…
Eli Lilly began world’s first study of a potential COVID-19 antibody treatment in humans
On Jun. 1, 2020, Eli Lilly announced patients had been dosed in the world’s first study of a…
CIRM board approved three projects targeting COVID-19
On May 29, 2020, the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs…
CIRM board expanded efforts of COVID-19 program
On May 22, 2020, the California Institute for Regenerative Medicine (CIRM) board expanded efforts related to the $5…
USC antibody study showed coronavirus infection more widespread in LA County than previously thought
On May 19, 2020, a University of Southern California (USC) study reported results from the first phase of…
CIRM board approved clinical trials targeting COVID-19 and sickle cell disease
On May 15, 2020, the California Institute for Regenerative Medicine (CIRM) board approved new clinical trials for COVID-19…
Catalent signed development agreement with Ennaid Therapeutics on its COVID-19 lead program
On May 13, 2020,Catalent announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at…
Lineage Cell Therapeutics to apply allogeneic dendritic cell therapy program to COVID-19 vaccine development
On May 6, 2020, Lineage Cell Therapeutics announced that it has applied for grant funding from the California…
City of Hope began CIRM-funded Coronavirus study
On Apr. 30, 2020, The California Institute for Regenerative Medicine (CIRM) awarded $750,000 to City of Hopeﾒs John…
Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda
On Apr. 30, 2020, Eiger BioPharmaceuticals announced that the first patients have been dosed in a Phase 2…
Texas A&M researchers lead testing of tuberculosis vaccine to fight COVID-19
On Apr. 29, 2020, a team of Texas A&M University researchers asked hundreds of frontline medical workers to…
CIRM Board funded first clinical study for COVID-19
On Apr. 24, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $749,999 to…
USC-LA County study showed early results of antibody testing suggest COVID-19 infections far exceeds number of confirmed cases in Los Angeles County
On Apr. 20, 2020, University of Southern California (USC) and the Los Angeles County Department of Public Health…
Biotechnology | COVID-19 | Diagnostics | Genomics | Medicine | Therapeutics
Iceland provides picture of early spread of COVID-19 in population with cohesive public health response
On Apr. 14, 2020, scientists at deCODE genetics and Iceland’s Directorate of Health and the National University Hospital…
Stanford-led team developed privacy-focused coronavirus alert app
On Apr. 9, 2020, James Petrie, a graduate student in applied mathematics at the University of Waterloo in…
Severely Ill COVID-19 patient at Southern California medical center extubated three days after treatment with CytoDyn’s leronlimab
On Apr. 9, 2020, CytoDyn announced a patient with severe COVID-19 under the care of a leading medical…
Harvard, MIT and Stanford commited to COVID-19 technology licensing principles, maximizing access to innovations
On Apr. 7, 2020, Harvard University, Massachusetts Institute of Technology, and Stanford University announced they had established and…
IGEA Pharma supplied COVID-19 antibody-based test in the US
On Apr. 6, 2020, IGEA Pharma announced that it was starting to supply of a COVID-19 antibody test…
New IHME COVID-19 forecasts find lower hospital bed need, epidemics starting to peak confirms social distancing works
On Apr. 5, 2020, updated COVID-19 estimates from the Institute for Health Metrics and Evaluation (IHME) found that…
Amgen and Adaptive Biotechnologies to develop a therapeutic to prevent or treat COVID-19
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
Adaptive Biotechnologies and Amgen announced collaboration to address COVID-19 pandemic
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
Amgen established Amgen Astellas BioPharma as wholly-owned affiliate In Japan
On Apr. 1, 2020, Amgen announced it had consummated the purchase from Astellas of 49% of shares of…
Cue Health awarded $13 million for rapid, portable, point-of-Care COVID-19 test by BARDA
On Mar. 31, 2020, Cue Health announced that is had been awarded up to $30 million in base…
The Institute for Molecular Medicine in Finland launched a COVID-19 Host Genetics Initiative
On Mar. 30, 2020, the Institute for Molecular Medicine in Finland (FIMM) announced it had launched a COVID-19…
COVID-19 Therapeutics Accelerator awarded $20 million in initial grants to fund clinical trials
On Mar. 30, 2020, the partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three…